Genmab A/S Proceeds From Exercise Of Warrants
Genmab A/S (GNMSF) reported Proceeds From Exercise Of Warrants of $23.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:ProceedsFromExerciseOfWarrants · last filed 2026-02-17
DKK
| Period end | Proceeds From Exercise Of Warrants 6 month | Proceeds From Exercise Of Warrants 12 month |
|---|---|---|
| 2024-12-31 | 129.00M DKK 6-K · filed 2025-02-12 | |
| 2024-06-30 | 75.00M DKK 6-K · filed 2024-08-08 | |
| 2023-12-31 | 152.00M DKK 6-K · filed 2025-02-12 | |
| 2023-06-30 | 103.00M DKK 6-K · filed 2024-08-08 | |
| 2022-12-31 | 280.00M DKK 6-K · filed 2025-02-12 | |
| 2022-06-30 | 34.00M DKK 6-K · filed 2023-08-03 | |
| 2021-12-31 | 135.00M DKK 6-K · filed 2024-02-14 | |
| 2021-06-30 | 46.00M DKK 6-K · filed 2022-08-10 | |
| 2020-12-31 | 140.00M DKK 6-K · filed 2023-02-22 | |
| 2019-12-31 | 65.00M DKK 6-K · filed 2022-02-16 |
USD
| Period end | Proceeds From Exercise Of Warrants 6 month | Proceeds From Exercise Of Warrants 12 month |
|---|---|---|
| 2025-12-31 | $23.00M 20-F · filed 2026-02-17 | |
| 2025-06-30 | $7.00M 6-K · filed 2025-08-07 | |
| 2024-12-31 | $19.00M 20-F · filed 2026-02-17 | |
| 2024-06-30 | $11.00M 6-K · filed 2025-08-07 | |
| 2023-12-31 | $21.00M 20-F · filed 2026-02-17 |